Physician
Associated Retinal Consultants, PC
Associated Retinal Consultants, PC was paid $21.12M by Medicaid between Jan 2018 and Dec 2024, across 28 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 55% of everything it billed.
33Billing provider infoASSOCIATED RETINAL CONSULTANTS, PC
ROYAL OAK, MI 48073
ROYAL OAK, MI 48073
33aNPI1215003793assigned 11/28/2006
33bProvider typeOphthalmology Physician
28Total paid$21.12M
24GClaims144,122
24DCodes billed28
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Michigan
Rank by total paid#1 of 106
Median peer was paid$51K
This provider vs. median413×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,352 | $2.67M | |
| 2019 | 20,182 | $2.62M | |
| 2020 | 16,296 | $2.50M | |
| 2021 | 20,534 | $3.17M | |
| 2022 | 21,684 | $3.27M | |
| 2023 | 24,512 | $3.71M | |
| 2024incomplete | 20,562 | $3.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 55% | 10,548 | 10,210 | $11.70M |
| J2778 | Injection, ranibizumab, 0.1 mg | 23% | 7,523 | 7,250 | $4.86M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.2% | 22,653 | 21,874 | $1.11M |
| 67028 | Intravitreal injection of a pharmacologic agent | 3.8% | 24,990 | 23,691 | $799K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 2.2% | 447 | 431 | $468K |
| 92134 | 2.1% | 31,895 | 31,133 | $451K | |
| 92235 | 1.0% | 4,153 | 4,113 | $218K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.0% | 4,251 | 3,942 | $214K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.0% | 8,267 | 8,118 | $213K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 2,439 | 2,433 | $207K |
| 92250 | <1% | 8,750 | 8,499 | $167K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,719 | 1,442 | $163K |
16 more codes
| 99205 | Prolong outpt/office vis | <1% | 822 | $93K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,355 | $90K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,056 | $70K |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | <1% | 79 | $56K |
| 92226 | <1% | 4,298 | $55K | |
| 67228 | <1% | 330 | $54K | |
| 92201 | <1% | 3,604 | $47K | |
| 76512 | <1% | 951 | $26K | |
| 67113 | <1% | 51 | $24K | |
| 92225 | <1% | 1,250 | $18K | |
| J3590 | Unclassified biologics | <1% | 125 | $6K |
| 92202 | <1% | 826 | $6K | |
| 92227 | <1% | 580 | $5K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 123 | $2K |
| J7999 | Compounded drug, not otherwise classified | <1% | 16 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21 | $257.99 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUBY, ALAN (OWNER)